Cart 0


The Annual Scientific Conference on Sickle Cell and Thalassaemia is one of the must attend events of the year for consultants and specialist psychologists, nurses, scientists and all relevant experts. The event is an ideal opportunity to see the latest advances in diagnosis, treatment and emerging fields in haemoglobinopathies. It is an opportunity to interact on the latest advances in clinical care, transition services and emerging new therapies including updates for curative treatment options. Furthermore, you will have the opportunity to show case your work through abstracts (oral and posters) and to network with leading and cutting edge practitioners.

2018 ASCAT Conference Images

Photos taken by Vivien Kakaan - VivienNaomi Photography

This year’s theme is ‘Sickle cell and Thalassaemia disorders new treatment horizon; while ensuring patient safety and delivering excellence in routine patient care’ ; seeking to build on the previous meetings themes and address some of the areas that delegates suggest further coverage. With the emergence of new therapies in the horizon and the complexities in decision making, challenges in funding; new strategies are required to ensure the sustainable programme. This is relevant in all settings including developed countries where disparities still exist and professional and user engagement is limited.

In 2019 we plan to address a wide variety of topics including: Implementation of Newborn Screening for hemoglobinopathies, cohort’s studies, and the development of management protocols and national control programmes.

  • New therapies including clinical trials at different stages- Phase I/II/III in sickle cell disease and thalassaemia

  • Update on Gene therapies, gene editing and bone marrow transplantation

  • Psychosocial aspects including body, mind and health related quality of life in sickle cell disease and thalassaemia

  • Blood transfusion including apheresis, iron chelation therapy and acute haemolytic complications.

  • Quality standards in the diagnosis, treatment of sickle cell and thalassaemia- Global priorities

  • We plan to run ‘meet the expert’ sessions, seminars and tutorials.

A full patient forum to involve children and adults and parents experience will be shared during the three days.

Highlights to include prizes for top oral and poster presentations, with the opportunity to receive free registration and cash supplements for the winners of the competition.



  • Abstract presentations and poster presentation for early stage and established researchers

  • Webinars for prime-time lectures and debate

  • Exhibitions

  • CPD/CME points have been applied for from the Royal College of Paediatrics and Child Health and the Royal College Pathologists.

  • Networking opportunities with more than 200 professionals

  • World-renowned experts in the field of Sickle-cell Thalassaemia


Event Date:

21 Oct 2019 -
23 Oct 2019



Westminster Bridge - County Hall
Belvedere Road
London SE1 7PB



08:30 - 16:30
GMT Time



Steering Committee

Photos by Vivien Kakaan - VivienNaomi Photography

Dr Baba Inusa - Lead Sickle Cell and Thalassaemia, Evelina Hospital, London. Vice Chairman, Sickle Cell Cohort Research.

Dr Baba Inusa - Lead Sickle Cell and Thalassaemia, Evelina Hospital, London. Vice Chairman, Sickle Cell Cohort Research.

Baba Inusa is a professor of Paediatric Haematology, King’s College London and lead consultant for haemoglobinopathies at Evelina Hospital London, Guy’s and St Thomas NHS Trust.

He is the founder of Academy for Sickle Cell and Thalassaemia (ASCAT) and convenor of the scientific meeting in its’ 14th year. Founder, Sickle cell Cohort Research Foundation (SCORE), Nigeria. Steering committee member of 6 New SCD Drug Trials in the UK. Co-chair SCD treatment, American Society of Hematology (ASH) sickle cell initiative for Africa since 2014.

Main Research: Sickle Cell-Newborn screening and chronic organ damage, with over 60 publications.

Principal investigator for ‘African Research and Innovation Initiative for Sickle Cell Disease Education –improving research capacity for service improvement’ (ARISE).

Who should attend?

This three day conference is aimed at all those with a common interest in sickle cell and thalassaemia, including:

  • Consultant haematologists

  • Paediatricians

  • Psychologists

  • Scientists

  • Fellows and trainees in all related fields


The Annual Sickle Cell and Thalassaemia Conference 2019 will be held at:

Venues Westminster Bridge – County Hall
Belvedere Road



ascat18_group photo.jpg

For Sponsorship Queries : Email